The Experts below are selected from a list of 243 Experts worldwide ranked by ideXlab platform
W. H. Taylor - One of the best experts on this subject based on the ideXlab platform.
-
Comparative Pepstatin Inhibition Studies on Individual Human Pepsins and Pepsinogens 1,3 and 5(gastricsin) and Pig Pepsin A
Journal of Enzyme Inhibition and Medicinal Chemistry, 2003Co-Authors: N B Roberts, W. H. TaylorAbstract:Human gastric juice contains 3 major proteolytic components (pepsins1,3 and 5 or gastricsin). Pepsin 1 is increased in peptic ulcer and it's properties are relatively poorly understood. Studies with pepstatin the highly specific aspartic-protease inhibitor have therefore been carried out on individual active and proenzymes to assess any enzymic similarities. Human pepsin 1 was inhibited with high affinity similar to pepsin 3, whereas pepsin 5(gastricsin) was at least 40 times less sensitive. Inhibition of human pepsinogens 1,3 and 5 and pig pepsinogen A showed similar trends to the active enzymes. Studies using Sephadex gel filtration showed that pepstatin does not bind to pepsinogens and inhibition arises from pepstatin binding the pepsins released upon activation. Pepstatin inhibition was shown to be relatively independent of pH between 1.5 and 3.8 although at higher pH inhibition was less effective. The evidence suggests that pepsin 1 is similar to pepsin 3 and pepstatin inhibits by a one to one molecu...
-
Comparative Pepstatin Inhibition Studies on Individual Human Pepsins and Pepsinogens 1,3 and 5(gastricsin) and Pig Pepsin A
Journal of enzyme inhibition and medicinal chemistry, 2003Co-Authors: N B Roberts, W. H. TaylorAbstract:Human gastric juice contains 3 major proteolytic components (pepsins1,3 and 5 or gastricsin). Pepsin 1 is increased in peptic ulcer and it's properties are relatively poorly understood. Studies with pepstatin the highly specific aspartic-protease inhibitor have therefore been carried out on individual active and proenzymes to assess any enzymic similarities. Human pepsin 1 was inhibited with high affinity similar to pepsin 3, whereas pepsin 5(gastricsin) was at least 40 times less sensitive. Inhibition of human pepsinogens 1,3 and 5 and pig pepsinogen A showed similar trends to the active enzymes. Studies using Sephadex gel filtration showed that pepstatin does not bind to pepsinogens and inhibition arises from pepstatin binding the pepsins released upon activation. Pepstatin inhibition was shown to be relatively independent of pH between 1.5 and 3.8 although at higher pH inhibition was less effective. The evidence suggests that pepsin 1 is similar to pepsin 3 and pepstatin inhibits by a one to one molecular binding to the active site. The explanation for the reduced affinity of pepstatin to pepsin 5(gastricsin) needs further study by co-crystallisation X-ray analysis.
N B Roberts - One of the best experts on this subject based on the ideXlab platform.
-
Comparative Pepstatin Inhibition Studies on Individual Human Pepsins and Pepsinogens 1,3 and 5(gastricsin) and Pig Pepsin A
Journal of Enzyme Inhibition and Medicinal Chemistry, 2003Co-Authors: N B Roberts, W. H. TaylorAbstract:Human gastric juice contains 3 major proteolytic components (pepsins1,3 and 5 or gastricsin). Pepsin 1 is increased in peptic ulcer and it's properties are relatively poorly understood. Studies with pepstatin the highly specific aspartic-protease inhibitor have therefore been carried out on individual active and proenzymes to assess any enzymic similarities. Human pepsin 1 was inhibited with high affinity similar to pepsin 3, whereas pepsin 5(gastricsin) was at least 40 times less sensitive. Inhibition of human pepsinogens 1,3 and 5 and pig pepsinogen A showed similar trends to the active enzymes. Studies using Sephadex gel filtration showed that pepstatin does not bind to pepsinogens and inhibition arises from pepstatin binding the pepsins released upon activation. Pepstatin inhibition was shown to be relatively independent of pH between 1.5 and 3.8 although at higher pH inhibition was less effective. The evidence suggests that pepsin 1 is similar to pepsin 3 and pepstatin inhibits by a one to one molecu...
-
Comparative Pepstatin Inhibition Studies on Individual Human Pepsins and Pepsinogens 1,3 and 5(gastricsin) and Pig Pepsin A
Journal of enzyme inhibition and medicinal chemistry, 2003Co-Authors: N B Roberts, W. H. TaylorAbstract:Human gastric juice contains 3 major proteolytic components (pepsins1,3 and 5 or gastricsin). Pepsin 1 is increased in peptic ulcer and it's properties are relatively poorly understood. Studies with pepstatin the highly specific aspartic-protease inhibitor have therefore been carried out on individual active and proenzymes to assess any enzymic similarities. Human pepsin 1 was inhibited with high affinity similar to pepsin 3, whereas pepsin 5(gastricsin) was at least 40 times less sensitive. Inhibition of human pepsinogens 1,3 and 5 and pig pepsinogen A showed similar trends to the active enzymes. Studies using Sephadex gel filtration showed that pepstatin does not bind to pepsinogens and inhibition arises from pepstatin binding the pepsins released upon activation. Pepstatin inhibition was shown to be relatively independent of pH between 1.5 and 3.8 although at higher pH inhibition was less effective. The evidence suggests that pepsin 1 is similar to pepsin 3 and pepstatin inhibits by a one to one molecular binding to the active site. The explanation for the reduced affinity of pepstatin to pepsin 5(gastricsin) needs further study by co-crystallisation X-ray analysis.
Robert Brook - One of the best experts on this subject based on the ideXlab platform.
-
Adherence to the SEP-1 Sepsis Bundle in Hospital-Onset v. Community-Onset Sepsis: a Multicenter Retrospective Cohort Study
Journal of General Internal Medicine, 2020Co-Authors: Jonathan D. Baghdadi, Douglas Bell, Russell Kerbel, Daniel Z Uslan, Mitchell D Wong, Jack Needleman, William E Cunningham, Robert BrookAbstract:Background Sepsis is the leading cause of in-hospital death. The SEP-1 sepsis bundle is a protocol for early sepsis care that requires providers to diagnose and treat sepsis quickly. Limited evidence suggests that adherence to the sepsis bundle is lower in cases of hospital-onset sepsis. Objective To compare sepsis bundle adherence in hospital-onset vs. community-onset sepsis. Design Retrospective cohort study using multivariable analysis of clinical data. Participants A total of 4658 inpatients age 18 or older were identified by diagnosis codes consistent with sepsis or disseminated infection. Setting Four university hospitals in California between 2014 and 2016. Main Outcomes and Measures The primary outcome was adherence to key components of the sepsis bundle defined by the Centers for Medicare and Medicaid Services in their core measure, SEP-1. Covariates included clinical characteristics related to the patient, infection, and pathogen. Key Results Compared with community-onset, cases of hospital-onset sepsis were less likely to receive SEP-1 adherent care (relative risk 0.33, 95% confidence interval 0.29–0.38, p
James P Pitts - One of the best experts on this subject based on the ideXlab platform.
-
New and unusual host records for North American and South American spider wasps (Hymenoptera: Pompilidae).
Zootaxa, 2020Co-Authors: Frank E Kurczewski, Rick C West, Cecilia Waichert, Kelly C Kissane, Darrell Ubick, James P PittsAbstract:New and unusual host records for 133 species and subspecies of Pompilidae predominantly from the southwestern United States, Mexico, Central America, and South America are presented in modified taxonomic order. First-time species host records are given for Calopompilus Ashmead, Pepsis Fabricius, HemiPepsis Dahlbom, Priocnessus Banks, Entypus Dahlbom, Pompilocalus Roig-Alsina, Sphictostethus Kohl, Auplopus Spinola, Ageniella Banks, Eragenia Banks, Aporus Spinola, Poecilopompilus Ashmead, Tachypompilus Ashmead, Anoplius Dufour, Priochilus (Fabricius) and Notocyphus Smith. New host spider families are introduced for Calopompilus, Pepsis, HemiPepsis, Priocnessus, Entypus, Cryptocheilus Panzer, Priocnemis Schiødte, Auplopus, Ageniella, Eragenia, Aporus, Tachypompilus, Anoplius, Priochilus and Notocyphus. Eight host spider families are reported from the Western Hemisphere for the first time: Halonoproctidae (Notocyphus dorsalis dorsalis Cresson); Dipluridae (Pepsis pretiosa Dahlbom, P. montezuma Smith, P. infuscate Spinola, P. atripennis Fabricius, P. martini Vardy, Priocnessus vancei Waichert and Pitts); Nemesiidae (Pepsis pallidolimbata Lucas, P. viridis Lepeletier, P. spp., Pompilocalus hirticeps (Guérin), Sphictostethus gravesii (Haliday), S. striatulus Roig-Alsina, Priocnemis oregona Banks); Barychelidae (Eragenia sp.); Paratropididae (Pepsis stella Montet); Trechaleidae (HemiPepsis toussainti (Banks), Entypus unifasciatus cressoni (Banks), Tachypompilus ferrugineus (Say), Tachypompilus unicolor cerinus Evans, Priochilus gloriosum (Cresson); Desidae (Ageniella accepta (Cresson), Sphictostethus isodontus Roig-Alsina) and Selenopidae (Priochilus scrupulum (Fox), Tachypompilus erubescens (Taschenberg) or xanthopterus (Rohwer)). The first known host records for the rare South American pompilid genera Chirodamus (Lycosidae: Lycosa sp.) and Herbstellus (Nemesiidae: Diplothelopsis cf bonariensis Mello-Leitão) are presented.
-
new and unusual host records for north american and south american spider wasps hymenoptera pompilidae
Zootaxa, 2020Co-Authors: Frank E Kurczewski, Rick C West, Cecilia Waichert, Kelly C Kissane, Darrell Ubick, James P PittsAbstract:New and unusual host records for 133 species and subspecies of Pompilidae predominantly from the southwestern United States, Mexico, Central America, and South America are presented in modified taxonomic order. First-time species host records are given for Calopompilus Ashmead, Pepsis Fabricius, HemiPepsis Dahlbom, Priocnessus Banks, Entypus Dahlbom, Pompilocalus Roig-Alsina, Sphictostethus Kohl, Auplopus Spinola, Ageniella Banks, Eragenia Banks, Aporus Spinola, Poecilopompilus Ashmead, Tachypompilus Ashmead, Anoplius Dufour, Priochilus (Fabricius) and Notocyphus Smith. New host spider families are introduced for Calopompilus, Pepsis, HemiPepsis, Priocnessus, Entypus, Cryptocheilus Panzer, Priocnemis Schiodte, Auplopus, Ageniella, Eragenia, Aporus, Tachypompilus, Anoplius, Priochilus and Notocyphus. Eight host spider families are reported from the Western Hemisphere for the first time: Halonoproctidae (Notocyphus dorsalis dorsalis Cresson); Dipluridae (Pepsis pretiosa Dahlbom, P. montezuma Smith, P. infuscate Spinola, P. atripennis Fabricius, P. martini Vardy, Priocnessus vancei Waichert and Pitts); Nemesiidae (Pepsis pallidolimbata Lucas, P. viridis Lepeletier, P. spp., Pompilocalus hirticeps (Guerin), Sphictostethus gravesii (Haliday), S. striatulus Roig-Alsina, Priocnemis oregona Banks); Barychelidae (Eragenia sp.); Paratropididae (Pepsis stella Montet); Trechaleidae (HemiPepsis toussainti (Banks), Entypus unifasciatus cressoni (Banks), Tachypompilus ferrugineus (Say), Tachypompilus unicolor cerinus Evans, Priochilus gloriosum (Cresson); Desidae (Ageniella accepta (Cresson), Sphictostethus isodontus Roig-Alsina) and Selenopidae (Priochilus scrupulum (Fox), Tachypompilus erubescens (Taschenberg) or xanthopterus (Rohwer)). The first known host records for the rare South American pompilid genera Chirodamus (Lycosidae: Lycosa sp.) and Herbstellus (Nemesiidae: Diplothelopsis cf bonariensis Mello-Leitao) are presented.
Jonathan D. Baghdadi - One of the best experts on this subject based on the ideXlab platform.
-
Adherence to the SEP-1 Sepsis Bundle in Hospital-Onset v. Community-Onset Sepsis: a Multicenter Retrospective Cohort Study
Journal of General Internal Medicine, 2020Co-Authors: Jonathan D. Baghdadi, Douglas Bell, Russell Kerbel, Daniel Z Uslan, Mitchell D Wong, Jack Needleman, William E Cunningham, Robert BrookAbstract:Background Sepsis is the leading cause of in-hospital death. The SEP-1 sepsis bundle is a protocol for early sepsis care that requires providers to diagnose and treat sepsis quickly. Limited evidence suggests that adherence to the sepsis bundle is lower in cases of hospital-onset sepsis. Objective To compare sepsis bundle adherence in hospital-onset vs. community-onset sepsis. Design Retrospective cohort study using multivariable analysis of clinical data. Participants A total of 4658 inpatients age 18 or older were identified by diagnosis codes consistent with sepsis or disseminated infection. Setting Four university hospitals in California between 2014 and 2016. Main Outcomes and Measures The primary outcome was adherence to key components of the sepsis bundle defined by the Centers for Medicare and Medicaid Services in their core measure, SEP-1. Covariates included clinical characteristics related to the patient, infection, and pathogen. Key Results Compared with community-onset, cases of hospital-onset sepsis were less likely to receive SEP-1 adherent care (relative risk 0.33, 95% confidence interval 0.29–0.38, p